Because of the rarity of hepatic vein tumor thrombus (HVTT) compared with portal vein tumor
thrombus (PVTT) in patients with hepatocellular carcinoma, little is known about this disease …

Background & Aims The presence of portal vein tumor thrombosis (PVTT) in patients with
hepatocellular carcinoma (HCC) is regarded as indicating an advanced stage, and liver …

Background & Aims Presence of hepatic vein tumor thrombosis (HVTT) in patients with
hepatocellular carcinoma (HCC) is regarded as signaling an extremely poor prognosis …

AIM: To analyze hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis
(PVTT) using the tumor-node-metastasis (TNM) staging system. METHODS: We …

The role of hepatic resection in hepatocellular carcinoma (HCC) with accompanying portal
vein tumor thrombus (PVTT) remains controversial. This study aimed to evaluate the surgical …

Background Liver resection for hepatocellular carcinoma (HCC) patients with portal vein
tumor thrombus (PVTT) offers a chance of cure, although survival is often limited. The actual …

Background/purpose We aimed to correlate the survival of patients with hepatocellular
carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) who underwent …

Methods: Patients diagnosed as HCC with PVTT between January 2000 and December
2011 who received treatment with sorafenib, HR, or TACE were included. Patients with main …

The Barcelona Clinic Liver Cancer staging system recommends a tyrosine kinase inhibitor
(sorafenib) as standard therapy in advanced hepatocellular carcinoma (HCC) patients with …

Background The role of surgical resection and thrombectomy for hepatocellular carcinoma
(HCC) with portal vein tumor thrombus (PVTT) is controversial. This study aimed to evaluate …